Financial Analysis: Jushi (JUSHF) vs. Its Rivals

Jushi (OTCMKTS:JUSHFGet Free Report) is one of 54 publicly-traded companies in the “Medicinals & botanicals” industry, but how does it contrast to its peers? We will compare Jushi to related businesses based on the strength of its earnings, dividends, risk, analyst recommendations, institutional ownership, profitability and valuation.

Earnings & Valuation

This table compares Jushi and its peers top-line revenue, earnings per share and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Jushi $269.45 million -$65.10 million -2.20
Jushi Competitors $307.06 million -$158.05 million -9.94

Jushi’s peers have higher revenue, but lower earnings than Jushi. Jushi is trading at a higher price-to-earnings ratio than its peers, indicating that it is currently more expensive than other companies in its industry.

Insider and Institutional Ownership

21.7% of Jushi shares are owned by institutional investors. Comparatively, 15.3% of shares of all “Medicinals & botanicals” companies are owned by institutional investors. 21.0% of Jushi shares are owned by company insiders. Comparatively, 20.9% of shares of all “Medicinals & botanicals” companies are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.


This table compares Jushi and its peers’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Jushi -24.16% -214.72% -10.10%
Jushi Competitors -52.00% -55.96% -9.06%

Analyst Ratings

This is a summary of current recommendations for Jushi and its peers, as provided by

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Jushi 0 3 1 0 2.25
Jushi Competitors 243 544 913 66 2.45

As a group, “Medicinals & botanicals” companies have a potential upside of 59.98%. Given Jushi’s peers stronger consensus rating and higher probable upside, analysts plainly believe Jushi has less favorable growth aspects than its peers.


Jushi peers beat Jushi on 7 of the 12 factors compared.

About Jushi

(Get Free Report)

Jushi Holdings Inc., a vertically integrated cannabis company, engages in the cultivation, processing, retail, and distribution of medical and adult-use products. It focuses on building a portfolio of cannabis assets in various jurisdictions in Pennsylvania, Virginia, Ohio, Illinois, California, Nevada, and Massachusetts. The company also offers hemp-based CBD products, including cannabis dry flower, vaporizer forms of cannabis, edibles, cannabis oil in capsules, tinctures, cannabis in topical products, and other cannabis products, as well as vape cartridges, disposables, and concentrates under The Bank, The Lab, Nira+ Medicinals, Sèchè, Tasteology, and Hijinks brands. In addition, it operates medical cannabis dispensaries under the BEYOND/HELLO, Nature's Remedy, and NuLeaf brands. The company is headquartered in Boca Raton, Florida.

Receive News & Ratings for Jushi Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jushi and related companies with's FREE daily email newsletter.